Skip to content

ORBIMED ADVISORS LLC: FBRX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on FBRX, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 1,577,705 FBRX shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,577,705 shares
    Change vs previous 13F +380,750 shares

    0.64% of the 13F portfolio, value $33,526,231.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,196,955 shares
    Change vs previous 13F 0 shares

    0.68% of the 13F portfolio, value $31,001,135.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,196,955 shares
    Change vs previous 13F 0 shares

    0.67% of the 13F portfolio, value $32,640,963.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,196,955 shares
    Change vs previous 13F 0 shares

    0.43% of the 13F portfolio, value $17,954,325.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,196,955 shares
    Change vs previous 13F +603,867 shares

    0.39% of the 13F portfolio, value $15,476,628.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 593,088 shares
    Change vs previous 13F -6,912 shares

    0.11% of the 13F portfolio, value $4,602,363.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 600,000 shares
    Change vs previous 13F not available

    0.28% of the 13F portfolio, value $13,626,000.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).